The in vitro effects of pneumolysin, a sulfhydryl-activated toxin produced by Streptococcus pneumoniae, on various functions of human polymorphonuclear leukocytes (PMNLs) was investigated. Treatment of PMNLs with highly purified toxin significantly inhibited respiratory burst (in response to stimulation), ability to kill opsonized pneumococci, chemotaxis, and random migration. These inhibitions were observed at very low toxin doses (-1 hemolytic unit (2 ng) per 106 PMNLs), which had no effect on PMNL viability. These results suggest that pneumolysin could function in pathogenicity by interfering with the ability of PMNLs to migrate toward and kill pneumococci.
In a recent report (10) , we presented direct evidence for the involvement of pneumolysin, a sulfhydryl-activated cytolytic toxin produced by Streptococcus pneumoniae, in the pathogenicity of the organism. These studies showed that immunization of mice with a highly purified pneumolysin preparation significantly increased survival time after challenge with virulent S. pneumoniae.
Although it is known that pneumolysin binds to cholesterol in the plasma membrane of host cells (7) , its function in pathogenicity is not understood. Interference with the bactericidal function of polymorphonuclear leukocytes (PMNLs), which have been shown to bind pneumolysin (6) , is one possible mechanism whereby the toxin could enhance virulence. When PMNLs engulf microorganisms, they undergo a series of metabolic changes referred to as respiratory burst (11) . These changes result in increased production of H202 and other reactive oxygen species, which are an important component of the oxygen-dependent microbicidal system (11) . Consequently, any bacterial product that interferes with the respiratory burst of PMNLs could also affect their microbicidal function.
In the present study, we treated human PMNLs with low (sublethal) doses of highly purified pneumolysin and then examined their ability to undergo a respiratory burst in response to stimulation and their ability to kill pneumococci in vitro. The effects of toxin treatment on chemotaxis and random movement were also investigated.
MATERIALS AND METHODS
Purification of pneumolysin. Pneumolysin was purified from a type 1 strain of S. pneumoniae and assayed as previously described (10) . The final preparation migrated as a single major protein species (which accounted for greater than 97% of total protein) when analyzed by polyacrylamide gel electrophoresis in either the presence or absence of sodium dodecyl sulfate. The purified material had a specific activity of at least 500,000 hemolytic units (HU) per mg of protein (10) . (1 HU per ml will lyse 50% of a 1% suspension of human erythrocytes in 30 min at 370C).
Preparation of PMNLs. Blood was drawn from healthy volunteers into tubes containing lithium-heparin. PMNLs were separated by the rapid single-step method described by Ferrante and Thong (4 The tubes were gassed with 5% carbon dioxide-95% air and incubated at 37°C with end to end mixinig. Samples were taken at 0, 30, and 60 min, appropriately diluted in water, and plated onto blood agar to determine the number of viable bacteria.
Chemotaxis. PMNL chemotaxis and random movement were measured by the agarose technique (9) Statistical analysis. Differences between pneumolysin-treated and control PMNLs in the various experiments were analyzed with (two-tailed) paired t tests.
RESULTS
We examined the effects of pneumolysin on PMNL function over the concentration range of 0 to 100 HU/ml, which is equivalent to 0 to 2.5 HU per 106 PMNLs under our incubation conditions. It is probably more appropriate to express pneumolysin dosage in the latter manner, since it has been shown by Johnson et Initial experiments were set up to examine the effects of pneumolysin on the HMP shunt in nonstimulated PMNLs and in cells stimulated with zymosan particles (Fig. 1) . In the presence of zymosan, the HMP shunt activity of control PMNLs (those preincubated without pneumolysin) was 7.0 times greater than in nonstimulated cells. However, the presence of zymosan resulted in only a 2.1-fold stimulation of HMP shunt activity in PMNLs treated with 2.5 HU of pneumolysin per 106 cells. There was a progressive decrease in HMP shunt activity in the presence of zymosan with increasing pneumolysin dose, and this became statistically significant at 0.25 HU per 106 PMNLs. In nonstimulated PMNLs, there was a slight increase in HMP shunt activity after pneumolysin treatment. This was statistically sikiificant at 1.25 HU per 106 PMNLs but not at any other dose.
The effect of pneumolysin treatment on the respiratory burst of PMNLs was fiirther investigated by measuring H202 production (Fig. 2) (Fig. 3a) . The inhibitory effect of pneumolysin became more evident at the higher ratios of bacteria to PMNLs (Fig. 3b  and c) Effect of pneumolysin on PMNL chemotaxis and random migration. Although PMNLs have an extremely potent microbicidal machinery, its effective deployment depends on the ability of the cells to reach the bacteria. Thus, the effects of pneumolysin on PMNL chemotaxis and random migration were investigated (Fig. 4) . At the maximum concentration of 0.5 HU per 106 PMNL, the toxin caused a 43% inhibition of chemotaxis and a 59% inhibition of random migration. Significant inhibition of chemotactic responsiveness and random migration was observed at 0.25 and 0.125 HU per 106 PMNL, respectively.
Effect of cholesterol on inhibitory properties of pneumolysin. To determine whether the inhibitory effects of purified pneumolysin on PMNL function were due to its specificity for cholesterol, the toxin was preincubated with 2 jig of cholesterol per 1,000 HU. Such treatment caused greater than 95% inhibition of toxin hemolytic activity. The experiments described in Fig. 1 to 4 were then repeated using the 
DISCUSSION
In a recent report (10), we presented direct evidence for the involvement of pneumolysin in the pathogenicity of S. pneumoniae. These studies showed that immunization of mice with a highly purified preparation of pneumolysin increased survival time after challenge with virulent pneumococci. Results presented here suggest that pneumolysin could function in pathogenesis by interfering with the antimicrobial activity of PMNLs. The results presented also confirm the previous finding of Johnson et al. (6) that pneumolysin inhibits the chemotactic response and random migration of human PMNLs. From our studies, a toxin dose as low as 0.25 HU/106 PMNLs caused significant inhibition of both chemotaxis and random migration.
The oxygen-dependent antimicrobial system is the most potent microbicidal property of the PMNL. An important component of this system, the respiratory burst which accompanies phagocytosis, was inhibited by pneumolysin. This was demonstrated by inhibition of both the burst of HMP shunt activity and H202 production. The inhibition of this biochemical system was correlated with an inhibition of the ability of human PMNLs to kill S. pneumoniae in vitro. All these effects were observed at toxin concentrations that had no effect on the viability of PMNLs.
Andersen and Duncan (1) have previously reported that the related streptococcal toxin, streptolysin 0, stimulated the metabolic activity of resting human PMNLs, as measured by chemiluminescence and 02 consumption. This stimulation, which was only slight when compared with that induced by the addition of zymosan, may be analogous to the similarly slight but significant stimulation of HMP shunt activity observed in the present study when PMNLs were treated with 1.25 HU of pneumolysin per 106 cells in the absence of zymosan. Unfortunately, a comparison of the effects of pneumolysin and streptolysin 0 on the metabolic activity of stimulated PMNLs is not possible because data for the latter toxin are not available. Mem- brane-active toxins that are structurally unrelated to pneumolysin have also been shown to affect human PMNLs. Cavalieri and Snyder (2) have reported that Escherichia coli alpha-toxin stimulated chemiluminescence of PMNLs but inhibited chemotaxis, phagocytosis, and bactericidal activity. Conversely, staphylococcal alpha-toxin has been shown to enhance PMNL phagocytosis and bactericidal activity (5) .
It has been suggested that release of reactive oxygen metabolites from PMNLs is a principal mediator in inflammatory tissue injury during a pneumococcal infection (8) . However, the present finding shows that the maximal respiratory burst of PMNLs is markedly depressed by pneumolysin. Therefore, a more attractive explanation for tissue damage is that put forward by Johnson et al. (6) that pneumolysin enhances release of lysozyme and possibly other hydrolytic enzymes from PMNLs. Although a rise in serum antibody to pneumolysin has been detected in a proportion of patients with pneumococcal pneumonia (12), the actual amount of toxin produced by S. pneumoniae in vivo is not known. Nevertheless, our observation that pneumolysin inhibits PMNL antimicrobial function at an extremely low dose of <1 HU (2 ng) per 106 PMNLs implies that this finding is likely to be of relevance in vivo.
